Company:  REPLIGEN CORP (RGEN)
Form Type:  10-Q
Filing Date:  11/8/2012 
CIK:  0000730272 
Address:  41 SEYON STREET
BUILDING 1, SUITE 100
 
City, State, Zip:  WALTHAM, Massachusetts 02453 
Telephone:  (781) 449-9560 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$15.66  
Change: 
-0.18 (-1.14%)  
Trade Time: 
Apr 24  
Market Cap: 
$501.75M
Description of Business
The following discussion of our business contains forward-looking statements that involve risks and uncertainties. When used in this report, the words �intend,� �anticipate,� �believe,� �estimate,� �plan� and �expect� and similar expressions as they relate to us are included to identify forward-looking statements. Our actual results could differ materially from those anticipated in these forward-looking statements and are a result of certain factors, including those set forth under �Risk Factors� and elsewhere in this Annual Report on Form 10-K. Overview Repligen Corporation (�Repligen,� the �Company� or �we�) is a life sciences company that develops, manufactures and markets high-value, consumable bioprocessing products for life sciences and biopharmaceutical companies worldwide. We are a world-leading manufacturer of both native and recombinant forms of Protein A, critical reagents used in biomanufacturing to purify monoclonal antibodies, a type of biologic drug.
Register for EDGAR Pro and access this filing in:     
  FORM 10-Q
    PART I
      FINANCIAL STATEMENTS
        BALANCE SHEET
        CASH FLOW
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
      ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL ...
      ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT ...
      ITEM 4. CONTROLS AND PROCEDURES
    PART II. OTHER INFORMATION
      ITEM 1. LEGAL PROCEEDINGS
      ITEM 1A. RISK FACTORS
      ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF ...
      ITEM 3. DEFAULTS UPON SENIOR SECURITIES
      ITEM 4. MINE SAFETY DISCLOSURES
      ITEM 5. OTHER INFORMATION
      ITEM 6. EXHIBITS
    SIGNATURES
    EXHIBIT INDEX
  EXHIBIT 31.1
    CERTIFICATION
  EXHIBIT 31.2
    CERTIFICATION
  EXHIBIT 32.1
    CERTIFICATION PURSUANT TO
BROKERAGE PARTNERS